Reduced Food and Calorie Intake Because semaglutide reduces appetite and delays stomach emptying, some people unintentionally skip meals or consume far fewer calories than usual
It is currently undergoing a phase 3 trial (NCT05564169) with 600 participants, employing a randomized, double-blind, placebo-controlled, parallel-group design over 24 weeks, followed by a 24-week extension phase
Coverage varies depending on your insurance plan and the services provided
[1] [8] It can be used as monotherapy when metformin is inappropriate, or as an add-on therapy in combination with other diabetes medications
Where tirzepatide is a dual agonist (GLP-1 + GIP), retatrutide is a triple agonist (GLP-1 + GIP + glucagon receptor)
Liu Y, Chen S, Yu L, Deng Y, Li D, Yu X, et al